Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Entourage Health Corp V.ENTG

Alternate Symbol(s):  ETRGF

Entourage Health Corp. is a Canada-based license holder producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 26,000 square feet indoor facility in Aylmer, Ontario (the Aylmer Facility), specializing in product development and fulfillment for both adult-use and medical cannabis. The Company is focused on building a portfolio of... see more

TSXV:ENTG - Post Discussion

Entourage Health Corp > ENTG ...Record Q2 Revenues of $13.6 Million
View:
Post by HappyFlowers25 on Jul 20, 2021 10:39am

ENTG ...Record Q2 Revenues of $13.6 Million

--------------ntourage Health Announces Preliminary Record Q2 Revenues of $13.6 Million and Confirms Financial Results Call to be Held on August 10, 2021 at 10 a.m. ET Entourage Health Corp.--------------------------------------https://entouragehealthcorp.com/press-releases/entourage-health-announces-preliminary-record-q2-revenues-of-136-million-and-confirms-financial-results-call-to-be-held-on-august-10-2021-at-10-am-et
Comment by InvestingFool50 on Jul 21, 2021 11:50am
So, a million more than last Q, and not including the acquisition. Anyone hear how much the revenue of cann(acquisition) was yearly??
Comment by Nicksonsnowboar on Jul 22, 2021 4:13pm
No surprise ,not well recieved only difference is people are trying to bail out at .28 instead of .29 and volume is anemic  . Nothing changed other than the name. 
Comment by Robotme on Jul 22, 2021 5:56pm
Still salty about the losses you made here then?  
Comment by Nicksonsnowboar on Jul 22, 2021 9:05pm
Usually i would not respond.  But what the heck ,  no i have not lost any on this spec stock nor have i made any.  Learned long ago that these spec stocks are high risk and are run by snake oil sales men. Many moons ago i lost a fair hunk of change on a spec stock. bought it low watch it take off never sold  as greed kicked in  and watched it fall . I still hold this stock ...more  
Comment by Robotme on Jul 23, 2021 9:28am
  You hope they survive and thrive??? Other than saying that just now, everything you've ever posted has been diametrically opposed to that statement. You're saying "I didn't eat the cookie" with crumbs all over your face and half the cookie still in your hand.   
Comment by Nicksonsnowboar on Jul 23, 2021 10:20am
A stock is just a thing  i neither hate it or love it.  Follow the trend , right now they have shown nothing of substance and it is indicative in the stock value and volume.  
Comment by Robotme on Jul 23, 2021 7:28pm
You don't hate it? You're a horrible liar. Your post history is public, you might want to think about that for a minute. You have been seething constantly. Actions speak louder than words. And your action of constantly typing vitriolic comments on this board, says otherwise. You don't hate it... I hope that was a joke because, again, everything you've typed is PUBLIC.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities